Clinical and therapeutic variables influencing hospitalisation for bronchiolitis in a community-based paediatric group practice

Primary Care Respiratory Journal

Volumn 16, Issue 2, 2007, Pages 93-97

  Al Shawwa, Baha ^a,d   Al Huniti, Nidal ^b   Weinberger, Miles ^c   Abu Hasan, Mutasim ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b PHARSIGHT CORPORATION   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Children's Hospital of Wisconsin   (United States)

Author keywords

Albuterol; Bronchiolitis; Corticosteroids, respiratory syncytial virus; Hospitalisation

Indexed keywords

CORTICOSTEROID; SALBUTAMOL; TOBACCO SMOKE;

AGE DISTRIBUTION; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHIOLITIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; OUTCOME ASSESSMENT; OUTPATIENT; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; WHEEZING;

ADRENAL CORTEX HORMONES; ADRENERGIC AGONISTS; ALBUTEROL; BRONCHIOLITIS; ENVIRONMENTAL EXPOSURE; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; TOBACCO SMOKE POLLUTION;

EID: 34247898983     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2007.00018     Document Type: Article

References (24)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. Jama 1999;282(15):1440-6.
2. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000;137(6):865-70.
3. Howard TS, Hoffman LH, Stang PE, Simoes EA. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. J Pediatr 2000;137(2):227-32.
4. Meissner HC. Economic impact of viral respiratory disease in children. J Pediatr 1994;124(5 Pt 2):S17-21.
5. Bronchiolitis-associated outpatient visits and hospitalizations among American Indian and Alaska Native children - United States, 1990-2000. MMWR Morb Mortal Wkly Rep 2003;52(30):707-10.
6. Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 1996;348(9023):292-5.
7. Berger I, Argaman Z, Schwartz SB, et al. Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr Pulmonol 1998;26(3):162-6.
8. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: A meta-analysis. Pediatrics 2000;105(4):E44.
9. De Boeck K, Van der Aa N, Van Lierde S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. J Pediatr 1997;131(6):919-21.
10. van Woensel JB, Wolfs TF, van Aalderen WM, Brand PL, Kimpen JL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997;52(7):634-7.
11. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991;118(5):807-11.
12. Gadomski AM, Lichenstein R, Horton L, King J, Keane V, Permutt T. Efficacy of albuterol in the management of bronchiolitis. Pediatrics 1994;93(6 Pt 1):907-12.
13. Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100(2 Pt 1):233-39.
14. Weinberger M. Corticosteroids for first-time young wheezers: current status of the controversy. J Pediatr 2003;143(6):700-02.
15. Csonka P, Kaila M, Laippala P, Iso-Mustajarvi M, Vesikari T, Ashorn P. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr 2003;143(6):725-30.
16. Schuh S, Coates AL, Binnie R, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr 2002;140(1):27-32.
17. Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 1993;15(1):19-27.
18. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995;95(4):500-05.
19. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 2003;362(9394):1433-8.
20. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2000(2):CD001266.
21. Lanari M, Giovannini M, Giuffre L, et al. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr Pulmonol 2002;33(6):458-65.
22. Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 2003;22(2 Suppl):S13-18; discussion S18-20.
23. Cifuentes L, Caussade S, Villagran C, et al. Risk factors for recurrent wheezing following acute bronchiolitis: a 12-month follow-up. Pediatr Pulmonol 2003;36(4):316-21.
24. Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med 2002;96(Suppl B):S1-7.